CervoMed (CRVO) Net Income towards Common Stockholders (2022 - 2025)
Historic Net Income towards Common Stockholders for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to -$7.7 million.
- CervoMed's Net Income towards Common Stockholders fell 6251.91% to -$7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.6 million, marking a year-over-year decrease of 11409.22%. This contributed to the annual value of -$16.3 million for FY2024, which is 11452.27% down from last year.
- Per CervoMed's latest filing, its Net Income towards Common Stockholders stood at -$7.7 million for Q3 2025, which was down 6251.91% from -$6.2 million recorded in Q2 2025.
- In the past 5 years, CervoMed's Net Income towards Common Stockholders registered a high of -$882623.0 during Q3 2022, and its lowest value of -$7.7 million during Q3 2025.
- In the last 4 years, CervoMed's Net Income towards Common Stockholders had a median value of -$2.6 million in 2023 and averaged -$3.7 million.
- Within the past 5 years, the most significant YoY rise in CervoMed's Net Income towards Common Stockholders was 4205.55% (2023), while the steepest drop was 19773.63% (2023).
- Quarter analysis of 4 years shows CervoMed's Net Income towards Common Stockholders stood at -$4.1 million in 2022, then surged by 42.06% to -$2.4 million in 2023, then tumbled by 184.05% to -$6.7 million in 2024, then decreased by 15.16% to -$7.7 million in 2025.
- Its Net Income towards Common Stockholders stands at -$7.7 million for Q3 2025, versus -$6.2 million for Q2 2025 and -$4.9 million for Q1 2025.